These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17420946)

  • 1. Nimesulide inhibits crypt epithelial cell proliferation at 6 hours in the small intestine in CD-1 mice.
    McGarvey MA; O'Kelly F; Ettarh RR
    Dig Dis Sci; 2007 Sep; 52(9):2087-94. PubMed ID: 17420946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimesulide alters cell recruitment into mitosis in murine intestinal crypts without influencing the cell production rate.
    McGarvey MA; Bass G; Ettarh RR
    Dig Dis Sci; 2007 Jun; 52(6):1471-8. PubMed ID: 17429722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism.
    Riehl T; Cohn S; Tessner T; Schloemann S; Stenson WF
    Gastroenterology; 2000 Jun; 118(6):1106-16. PubMed ID: 10833485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing mechanisms of inhibition of calcium increases in human uterine myocytes by indomethacin and nimesulide.
    Landen CN; Zhang P; Young RC
    Am J Obstet Gynecol; 2001 May; 184(6):1100-3. PubMed ID: 11349169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nimesulide and indomethacin on contractility and the Ca2+ channel current in myometrial smooth muscle from pregnant women.
    Sawdy R; Knock GA; Bennett PR; Poston L; Aaronson PI
    Br J Pharmacol; 1998 Nov; 125(6):1212-7. PubMed ID: 9863649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats.
    Bukowski R; McKay L; Shi SQ; Saade GR; Garfield RE
    Am J Obstet Gynecol; 2001 Oct; 185(4):959-65. PubMed ID: 11641685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrocortisone and indomethacin negatively modulate EGF-R signaling in human fetal intestine.
    Kajanne R; Leppä S; Luukkainen P; Ustinov J; Thiel A; Ristimäki A; Miettinen PJ
    Pediatr Res; 2007 Nov; 62(5):570-5. PubMed ID: 17805209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
    Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B
    J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR signaling is involved in indomethacin and nimesulide suppression of colorectal cancer cell growth via a COX-2 independent pathway.
    Zhang YJ; Bao YJ; Dai Q; Yang WY; Cheng P; Zhu LM; Wang BJ; Jiang FH
    Ann Surg Oncol; 2011 Feb; 18(2):580-8. PubMed ID: 20803081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.
    Kitamura T; Itoh M; Noda T; Matsuura M; Wakabayashi K
    Int J Cancer; 2004 Apr; 109(4):576-80. PubMed ID: 14991580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitors.
    Shahbazian A; Schuligoi R; Heinemann A; Peskar BA; Holzer P
    Br J Pharmacol; 2001 Mar; 132(6):1299-309. PubMed ID: 11250881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nimesulide and indometacin on COX-1 and COX-2: a comparative study.
    de Leval X; Dogné JM; Neven P; Labasse A; Delarge J; Reginster JY; Henrotin Y
    J Pharm Belg; 1999; 54(3):89-90. PubMed ID: 10431478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity.
    Kim TI; Lee YC; Lee KH; Han JH; Chon CY; Moon YM; Kang JK; Park IS
    Infect Immun; 2001 Aug; 69(8):5056-63. PubMed ID: 11447186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nonselective and selective cyclooxygenase inhibitors on small intestinal motility in the horse.
    Menozzi A; Pozzoli C; Poli E; Dacasto M; Giantin M; Lopparelli RM; Passeri B; Zullian C; Gobbetti T; Bertini S
    Res Vet Sci; 2009 Feb; 86(1):129-35. PubMed ID: 18565556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
    Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
    J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonistic properties of the cyclooxygenase-2 inhibitor nimesulide in human myometrial myocytes.
    Knock GA; Aaronson PI
    Br J Pharmacol; 1999 Jul; 127(6):1470-8. PubMed ID: 10455298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimesulide-induced antipyresis in rats involves both cyclooxygenase-dependent and independent mechanisms.
    Werner MF; Souza GE; Zampronio AR
    Eur J Pharmacol; 2006 Aug; 543(1-3):181-9. PubMed ID: 16814279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1.
    Cohn SM; Schloemann S; Tessner T; Seibert K; Stenson WF
    J Clin Invest; 1997 Mar; 99(6):1367-79. PubMed ID: 9077547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
    Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
    J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
    Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
    Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.